MC
BSX icon

Menta Capital’s Boston Scientific BSX Stock Holding History

Menta Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,832
Closed -$456K – 551
2018
Q3 		$456K Sell
11,832
-13,868
-54% -$484K 0.16% 244
2018
Q2 		$840K Buy
+25,700
New +$775K 0.2% 185
2017
Q1 		– Sell
-133,850
Closed -$2.9M – 815
2016
Q4 		$2.9M Buy
133,850
+123,600
+1,206% +$2.7M 0.24% 101
2016
Q3 		$244K Buy
+10,250
New +$245K 0.02% 708
2013
Q3 		– Sell
-26,900
Closed -$249K – 368
2013
Q2 		$249K Buy
+26,900
New +$228K 0.16% 267

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Menta Capital's BSX Position: Q4 2018 in Review

Menta Capital sold out of Boston Scientific (BSX) in Q4 2018, closing a stake of 11,832 shares — an estimated $456K sold.

Menta Capital first reported a position in BSX in Q2 2013 and held it in 5 quarters. The position peaked at $2.9M in Q4 2016. 730 funds tracked by Wall St. Rank hold BSX as of Q4 2018.

  • Menta Capital reported no remaining Boston Scientific position as of Q4 2018 after selling out during the quarter.
  • Menta Capital sold 11,832 Boston Scientific shares in Q4 2018, an estimated $456K.
  • Menta Capital first reported a position in Boston Scientific in Q2 2013 and held it in 5 quarters.
  • Menta Capital's Boston Scientific position peaked at $2.9M in Q4 2016.
  • 730 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2018.

Based on Menta Capital's 13F filing for Q4 2018, filed 14 Feb 2019.